Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Read More…
Industry, Sector and Symbol
Industry Toilet preparations
Sub-IndustryHousehold Products
SectorConsumer Staples
Phone212-310-2000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$15.54 billion
Profitability
Miscellaneous
Employees34,500
Next Earnings Date10/25/2019 (Estimated)
OptionableOptionable
Colgate-Palmolive (NYSE:CL) Frequently Asked Questions
What is Colgate-Palmolive's stock symbol?
Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."
How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?
Colgate-Palmolive declared a quarterly dividend on Thursday, June 20th. Investors of record on Thursday, July 18th will be given a dividend of $0.43 per share on Thursday, August 15th. This represents a $1.72 dividend on an annualized basis and a yield of 2.37%. The ex-dividend date of this dividend is Wednesday, July 17th. View Colgate-Palmolive's Dividend History.
How will Colgate-Palmolive's stock buyback program work?
Colgate-Palmolive declared that its board has authorized a share repurchase program on Monday, June 18th 2018, which allows the company to buyback $5,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to reacquire up to 9% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's leadership believes its shares are undervalued.
How were Colgate-Palmolive's earnings last quarter?
Colgate-Palmolive (NYSE:CL) released its quarterly earnings data on Friday, July, 26th. The company reported $0.72 earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of $0.72. The company earned $3.87 billion during the quarter, compared to analysts' expectations of $3.88 billion. Colgate-Palmolive had a negative return on equity of 10,821.98% and a net margin of 14.77%. Colgate-Palmolive's revenue was down .5% on a year-over-year basis. During the same period in the prior year, the company posted $0.77 earnings per share. View Colgate-Palmolive's Earnings History.
When is Colgate-Palmolive's next earnings date?
What price target have analysts set for CL?
17 equities research analysts have issued 1-year target prices for Colgate-Palmolive's shares. Their forecasts range from $65.00 to $82.00. On average, they anticipate Colgate-Palmolive's share price to reach $73.6429 in the next year. This suggests a possible upside of 1.5% from the stock's current price. View Analyst Price Targets for Colgate-Palmolive.
What is the consensus analysts' recommendation for Colgate-Palmolive?
17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 1 sell rating, 10 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Colgate-Palmolive.
What are Wall Street analysts saying about Colgate-Palmolive stock?
Here are some recent quotes from research analysts about Colgate-Palmolive stock:
- 1. Wells Fargo & Co analysts commented, "We are raising our price target by $3 to $68 to reflect CL’s fundamental progress to date, but maintain our Market Perform rating largely on valuation." (6/17/2019)
- 2. According to Zacks Investment Research, "Colgate surpassed the industry year to date owing to a robust surprise trend, which continued in first-quarter 2019. This marked the second straight quarter of sales beat and third positive earnings surprise of the last five quarters. Robust volumes and favorable pricing aided organic sales growth in the quarter. In 2019, the company expects benefits of pricing and productivity programs to considerably offset rise in raw material costs. Accelerated investments in brands, strong innovation, and expansion in new markets and channels, is likely to aid sales in 2019. However, the company is plagued with a soft margins and currency headwinds for a while now. Increased raw material and packaging costs as well as higher SG&A expenses are likely to hurt margins throughout 2019. Further, adverse currency should mar earnings and sales in 2019." (6/7/2019)
Has Colgate-Palmolive been receiving favorable news coverage?
Media coverage about CL stock has been trending positive this week, according to InfoTrie. The research firm identifies positive and negative media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Colgate-Palmolive earned a coverage optimism score of 2.5 on InfoTrie's scale. They also gave news stories about the company a news buzz of 6.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the company's share price in the near term. View News Stories for Colgate-Palmolive.
Are investors shorting Colgate-Palmolive?
Colgate-Palmolive saw a increase in short interest in July. As of July 31st, there was short interest totalling 11,271,000 shares, an increase of 12.6% from the June 30th total of 10,012,100 shares. Based on an average daily trading volume, of 3,340,000 shares, the days-to-cover ratio is presently 3.4 days. Approximately 1.3% of the shares of the company are sold short. View Colgate-Palmolive's Current Options Chain.
Who are some of Colgate-Palmolive's key competitors?
Some companies that are related to Colgate-Palmolive include Estee Lauder Companies (EL), Coty (COTY), Pola Orbis (PORBF), HYPERA S A/S (HYPMY), Inter Parfums (IPAR), Avon Products (AVP), Edgewell Personal Care (EPC), Mandom (MDOMF), Revlon (REV), e.l.f. Beauty (ELF), United-Guardian (UG), 2050 Motors (ETFM) and DS Healthcare Group (DSKX).
What other stocks do shareholders of Colgate-Palmolive own?
Who are Colgate-Palmolive's key executives?
Colgate-Palmolive's management team includes the folowing people:
- Mr. Ian M. Cook, Exec. Chairman (Age 66)
- Mr. Noel R. Wallace, Pres, CEO & Director (Age 55)
- Mr. Henning I. Jakobsen, Chief Financial Officer (Age 59)
- Mr. P. Justin Skala, Exec. VP and Chief Growth & Strategy Officer (Age 59)
- Dr. Patricia D. Verduin Ph.D., Chief Technology Officer (Age 60)
Who are Colgate-Palmolive's major shareholders?
Colgate-Palmolive's stock is owned by many different of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (8.92%), BlackRock Inc. (7.02%), Bank of New York Mellon Corp (2.37%), Northern Trust Corp (1.27%), Invesco Ltd. (1.01%) and Nuveen Asset Management LLC (0.75%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Prabha Parameswaran, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive.
Which major investors are selling Colgate-Palmolive stock?
CL stock was sold by a variety of institutional investors in the last quarter, including D. E. Shaw & Co. Inc., Morgan Stanley, AXA, Marathon Asset Management LLP, Commonwealth Bank of Australia, Renaissance Technologies LLC, Caisse DE Depot ET Placement DU Quebec and Amundi Pioneer Asset Management Inc.. Company insiders that have sold Colgate-Palmolive company stock in the last year include Dennis J Hickey, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Noel R Wallace, Patricia Verduin, Philip G Shotts, Prabha Parameswaran and Stephen I Sadove. View Insider Buying and Selling for Colgate-Palmolive.
Which major investors are buying Colgate-Palmolive stock?
CL stock was purchased by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Invesco Ltd., AQR Capital Management LLC, Vanguard Group Inc., Natixis, Panagora Asset Management Inc., California Public Employees Retirement System and Bank of New York Mellon Corp. View Insider Buying and Selling for Colgate-Palmolive.
How do I buy shares of Colgate-Palmolive?
Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Colgate-Palmolive's stock price today?
One share of CL stock can currently be purchased for approximately $72.56.
How big of a company is Colgate-Palmolive?
Colgate-Palmolive has a market capitalization of $62.26 billion and generates $15.54 billion in revenue each year. The company earns $2.40 billion in net income (profit) each year or $2.97 on an earnings per share basis. Colgate-Palmolive employs 34,500 workers across the globe.View Additional Information About Colgate-Palmolive.
What is Colgate-Palmolive's official website?
How can I contact Colgate-Palmolive?
Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]
MarketBeat Community Rating for Colgate-Palmolive (NYSE CL)
MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive and other stocks. Vote "Outperform" if you believe CL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CL will underperform the S&P 500 over the long term. You may vote once every thirty days.
